Autoimmune Archives | Be Korea-savvy

Celltrion Gets U.S. FDA Approval for New Biosimilar for Autoimmune Disease Treatment

SEOUL, Jan. 31 (Korea Bizwire) — Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA). The FDA approved Celltrion’s Avtozma, a biosimilar to Actemra, in both intravenous and subcutaneous formulations, according to the company. Avtozma [...]

South Korean Pharmaceutical Companies Make Bold Push Into Autoimmune Disease Market

SEOUL, Jan. 30 (Korea Bizwire) — South Korean drug manufacturers are rapidly expanding their presence in the global autoimmune disease treatment market, challenging the longtime dominance of Western pharmaceutical giants. Autoimmune diseases, which occur when the body’s immune system mistakenly attacks its own organs, tissues, and cells, encompass a range of conditions including rheumatoid arthritis, multiple sclerosis, [...]